Table of Contents Author Guidelines Submit a Manuscript
Multiple Sclerosis International
Volume 2017, Article ID 1359761, 6 pages
https://doi.org/10.1155/2017/1359761
Research Article

The Prevalence of Anti-Aquaporin 4 Antibody in Patients with Idiopathic Inflammatory Demyelinating Diseases Presented to a Tertiary Hospital in Malaysia: Presentation and Prognosis

1Division of Neurology, Department of Medicine, University Malaya Medical Centre, Kuala Lumpur, Malaysia
2Department of Medical Microbiology, University Malaya Medical Centre, Kuala Lumpur, Malaysia

Correspondence should be addressed to S. Abdullah; moc.oohay@80dbahaliahus

Received 5 September 2016; Revised 25 November 2016; Accepted 25 December 2016; Published 19 January 2017

Academic Editor: Bruno Brochet

Copyright © 2017 S. Abdullah et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. R. Cañellas, A. R. Gols, J. R. Izquierdo, M. T. Subirana, and X. M. Gairin, “Idiopathic inflammatory-demyelinating diseases of the central nervous system,” Neuroradiology, vol. 49, no. 5, pp. 393–409, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. À. Rovira, J. Sastre-Garriga, C. Auger, and A. Rovira, “Idiopathic inflammatory demyelinating diseases of the brainstem,” Seminars in Ultrasound, CT and MRI, vol. 34, no. 2, pp. 123–130, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. D. M. Wingerchuk, V. A. Lennon, S. J. Pittock, C. F. Lucchinetti, and B. G. Weinshenker, “Revised diagnostic criteria for neuromyelitis optica,” Neurology, vol. 66, no. 10, pp. 1485–1489, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. D. M. Wingerchuk, V. A. Lennon, C. F. Lucchinetti, S. J. Pittock, and B. G. Weinshenker, “The spectrum of neuromyelitis optica,” Lancet Neurology, vol. 6, no. 9, pp. 805–815, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. D. M. Wingerchuk, B. Banwell, J. L. Bennett et al., “International consensus diagnostic criteria for neuromyelitis optica spectrum disorders,” Neurology, vol. 85, no. 2, pp. 177–189, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. D. J. Kimbrough, K. Fujihara, A. Jacob et al., “Treatment of neuromyelitis optica: review and recommendations,” Multiple Sclerosis and Related Disorders, vol. 1, no. 4, pp. 180–187, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Osoegawa, J.-I. Kira, T. Fukazawa et al., “Temporal changes and geographical differences in multiple sclerosis phenotypes in Japanese: nationwide survey results over 30 years,” Multiple Sclerosis, vol. 15, no. 2, pp. 159–173, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. H. T. Chong, “Multiple sclerosis in South East Asia and diagnostic criteria for Asians,” Neurology Asia, vol. 13, no. 2, pp. 145–146, 2008. View at Google Scholar · View at Scopus
  9. S.-M. Kim, P. Waters, M. Woodhall et al., “Characterization of the spectrum of Korean inflammatory demyelinating diseases according to the diagnostic criteria and AQP4-Ab status,” BMC Neurology, vol. 14, no. 1, article no. 93, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Liu, G. X. Zhao, H. Yu, C. Z. Lyu, Z. X. Li, and Z. Y. Wu, “Differentiation of neuromyelitis optica from multiple sclerosis in a cohort from the mainland of China,” Chinese Medical Journal, vol. 127, no. 18, pp. 3213–3218, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Krumbholz, U. Hofstadt-van Oy, K. Angstwurm et al., “Very late-onset neuromyelitis optica spectrum disorder beyond the age of 75,” Journal of Neurology, vol. 262, no. 5, pp. 1379–1384, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. R.-D. Fernando, C. Juan-Pablo, M.-G. Maria-Luisa et al., “Neuromyelitis optica spectrum disorder in a ninety-year-old woman. A case report,” International Journal of Neurology and Neurotherapy, vol. 3, article 43, 2016. View at Google Scholar
  13. S. Siritho, I. Nakashima, T. Takahashi, K. Fujihara, and N. Prayoonwiwat, “AQP4 antibody-positive Thai cases: clinical features and diagnostic problems,” Neurology, vol. 77, no. 9, pp. 827–834, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. W. Kim, M. S. Park, S. H. Lee et al., “Characteristic brain magnetic resonance imaging abnormalities in central nervous system aquaporin-4 autoimmunity,” Multiple Sclerosis, vol. 16, no. 10, pp. 1229–1236, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Misu, K. Fujihara, I. Nakashima, S. Sato, and Y. Itoyama, “Intractable hiccup and nausea with periaqueductal lesions in neuromyelitis optica,” Neurology, vol. 65, no. 9, pp. 1479–1482, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Lee, A. Wang, and M. Yen, “Chiasmal optic neuritis: a report of three cases,” Taiwan Journal of Ophthalmology, vol. 2, no. 2, pp. 68–72, 2012. View at Publisher · View at Google Scholar
  17. S. Jarius, F. Paul, D. Franciotta et al., “Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica,” Nature Clinical Practice Neurology, vol. 4, no. 4, pp. 202–214, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Jarius, F. Paul, B. Wildemann et al., “Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures,” Journal of the Neurological Sciences, vol. 306, no. 1-2, pp. 82–90, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Matsuoka, T. Matsushita, Y. Kawano et al., “Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese,” Brain, vol. 130, no. 5, pp. 1206–1223, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Spadaro, L. A. Gerdes, M. Krumbholz et al., “Autoantibodies to MOG in a distinct subgroup of adult multiple sclerosis,” Neurology—Neuroimmunology Neuroinflammation, vol. 3, no. 5, article no. e257, 2016. View at Publisher · View at Google Scholar
  21. S. S. Zamvil and A. J. Slavin, “Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder?” Neurology - Neuroimmunology Neuroinflammation, vol. 2, no. 1, article e62, 2015. View at Publisher · View at Google Scholar
  22. J. Kitley, M. Woodhall, P. Waters et al., “Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype,” Neurology, vol. 79, no. 12, pp. 1273–1277, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Kitley, P. Waters, M. Woodhall et al., “Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies a comparative study,” JAMA Neurology, vol. 71, no. 3, pp. 276–283, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. D. K. Sato, D. Callegaro, M. A. Lana-Peixoto et al., “Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders,” Neurology, vol. 82, no. 6, pp. 474–481, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Jarius, K. Ruprecht, B. Wildemann et al., “Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: a multicentre study of 175 patients,” Journal of Neuroinflammation, vol. 9, article 14, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. C. T. Tan, “International consensus diagnostic criteria for neuromyelitis optica spectrum disorders,” Neurology, vol. 86, no. 5, pp. 491–492, 2016. View at Publisher · View at Google Scholar · View at Scopus
  27. V. A. Lennon, T. J. Kryzer, S. J. Pittock, A. S. Verkman, and S. R. Hinson, “IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel,” Journal of Experimental Medicine, vol. 202, no. 4, pp. 473–477, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. T. Takahashi, K. Fujihara, I. Nakashima et al., “Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre,” Brain, vol. 130, no. 5, pp. 1235–1243, 2007. View at Publisher · View at Google Scholar · View at Scopus